We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

ALIFAX DIAG/SRE

Develops automated diagnostic instruments for ESR testing and Bacterial Culture read more Featured Products: More products

Download Mobile App





Alifax S.r.l. Highlights First Automated System for Bacterial Culture and Susceptibility Testing

By LabMedica International staff writers
Posted on 20 Nov 2019
Print article
Image: Alifax HB&L (Photo courtesy of Alifax S.r.l.)
Image: Alifax HB&L (Photo courtesy of Alifax S.r.l.)
Alifax S.r.l. (Padua, Italy) highlighted its innovative diagnostic instrumentation portfolio at the 2019 edition of MEDICA, the world's largest trade fair for medical technology, held from 18 to 21 November in Düsseldorf, Germany.

Alifax is present in the laboratory diagnostic market and develops instruments and kits with a focus of the total laboratory automation requirements providing fast and reliable results, method standardization, sample traceability and easy-to-use protocols. Alifax’s innovative diagnostic products include Test1 and Roller 20 for the analysis of ESR in 20 seconds, Alfred AST sepsis analyzer for RAPID Bacterial Culture, antimicrobial susceptibility testing and MDRO screening and ALIBOX, a smart patented device designed to improve and certify bio-material transportation by active temperature control and multiple-parameter monitoring as temperature and location on a cloud-based service. It has also introduced the new I-dOne, a reagent free ATR-FTIR based system for microorganism identification in only one minute from isolated colony without sample preparation or pre-treatment.

At MEDICA 2019, Alifax highlighted its real walk-away automated streaking system for rapid bacterial culture and plate streaking of liquid samples that is composed of two units: Alfred 60AST and Sidecar. Alfred 60AST is the first fully automated system able to perform bacterial culture, RAA and susceptibility testing by automating the entire process of sample inoculation, reading and result transmission. Using patented technology based on light scattering, it is able to detect the presence of bacteria and their drug resistance in a few hours with high sensitivity and specificity. Alfred 60AST monitors the growth phases of bacteria from the inoculum step into specific culture broths, providing real time growth curves and quantitative bacterial count results in CFU/ml. Broth turbidity level is detected by the McFarland Monitor and as the sample reaches the 0.5 McFarland, it is buffered into the refrigerated area and then tested with a customized antibiotic panel. The Sidecar streaking unit stocks 240 Petri dishes and up to 12 different media. The streaked dishes are incubated on board at 37°C for the requested analysis time.

Alifax also highlighted HB&L, the first analyzer able to perform bacterial culture, RAA test and susceptibility testing on samples such as urine, sterile or non sterile fluids and other biological samples. Using patented technology based on light scattering, it can detect the presence of bacteria and their drug resistance in a few hours with high sensitivity and specificity. HB&L also monitors the growth phases of bacteria from the inoculum step into specific culture broths providing real time growth curves and quantitative bacterial count results in CFU/ml. Broth turbidity level is detected by McFarland Monitor and, as the sample reaches the 0.5 McFarland, a visual and audible alert advises that the bacterial culture is ready to be tested for a customized antibiotic panel without awaiting the end of the analysis and avoiding further dilution steps. HB&L’s software flexibility allows different tests to be performed simultaneously, with each reading unit position being independent from the others and can be set according to sample type, incubation time, test profile, analytical protocol and cut-off.

Related Links:
Alifax S.r.l.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.